AQST
AQST
NASDAQ · Pharmaceuticals

Aquestive Therapeutics Inc

$4.32
+0.09 (+2.13%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +499.5% upside
Low Target $17.61
Average Target $25.90
High Target $34.98
Current Price $4.32
Current
$4.32
Target
$25.90
$17.61 $25.90 avg $34.98
Scenario Analysis
Bear Case
$17.61
307.6%
Low target
Base Case
$25.90
+499.5%
Avg target
Bull Case
$34.98
+709.7%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$7.55
-42.8% from high
52-Week Low
$2.12
+103.8% from low
Target vs 52W High
$25.90
+243.0% vs high
Next Earnings Report
May 13, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.14
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%